These Analysts Revise Their Forecasts On Phreesia After Q2 Results

Benzinga Earnings

Yesterday

Phreesia Inc (NYSE:PHR) on Wednesday reported mixed second-quarter financial results.

Phreesia reported quarterly earnings of 3 cents per share which missed the analyst consensus estimate of 10 cents per share. The company reported quarterly sales of $129.458 million which beat the analyst consensus estimate of $129.069 million.

Phreesia affirmed its FY2027 sales guidance of $510.000 million to $520.000 million.

Phreesia shares fell 5.6% to trade at $11.21 on Thursday.

These analysts made changes to their price targets on Phreesia following earnings announcement.

Wells Fargo analyst Stan Berenshteyn maintained the stock with an Equal-Weight rating and raised the price target from $9 to $10.
Needham analyst Ryan MacDonald reiterated the stock with a Buy and maintained a $14 price target.
RBC Capital analyst Ryan Halsted reiterated the stock with an Outperform rating and maintained a $19 price target.

Considering buying PHR stock? Here’s what analysts think:

Photo via Shutetrstock

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2664487027"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2664487027\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2664487027?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-03 22:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2664487027","market":"us","top_or_hot":-1,"title":"These Analysts Revise Their Forecasts On Phreesia After Q2 Results","media":"Benzinga Earnings","content":"<html><body><p><strong>Phreesia Inc</strong> (NYSE:PHR) on Wednesday reported mixed second-quarter financial results.</p>\n<p>Phreesia reported quarterly earnings of 3 cents per share which missed the analyst consensus estimate of 10 cents per share. The company reported quarterly sales of $129.458 million which beat the analyst consensus estimate of $129.069 million.</p>\n<p>Phreesia affirmed its FY2027 sales guidance of $510.000 million to $520.000 million.</p>\n<p>Phreesia shares fell 5.6% to trade at $11.21 on Thursday.</p>\n<p>These analysts made changes to their price targets on Phreesia following earnings announcement.</p>\n<ul>\n<li><a href=\"https://laohu8.com/S/EOD\">Wells Fargo</a> analyst Stan Berenshteyn maintained the stock with an Equal-Weight rating and raised the price target from $9 to $10.</li>\n<li>Needham analyst Ryan MacDonald reiterated the stock with a Buy and maintained a $14 price target.</li>\n<li>RBC Capital analyst Ryan Halsted reiterated the stock with an Outperform rating and maintained a $19 price target.</li>\n</ul>\n<p><strong>Considering buying PHR stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"314\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/09/03102307/image-90-1024x314.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/09/03102307/image-90-1024x314.png 1024w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/09/03102307/image-90-300x92.png 300w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/09/03102307/image-90-768x235.png 768w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/09/03102307/image-90.png 1162w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutetrstock</em></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>These Analysts Revise Their Forecasts On Phreesia After Q2 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThese Analysts Revise Their Forecasts On Phreesia After Q2 Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga Earnings </p>\n<p class=\"h-time\">2026-09-03 22:24</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p><strong>Phreesia Inc</strong> (NYSE:PHR) on Wednesday reported mixed second-quarter financial results.</p>\n<p>Phreesia reported quarterly earnings of 3 cents per share which missed the analyst consensus estimate of 10 cents per share. The company reported quarterly sales of $129.458 million which beat the analyst consensus estimate of $129.069 million.</p>\n<p>Phreesia affirmed its FY2027 sales guidance of $510.000 million to $520.000 million.</p>\n<p>Phreesia shares fell 5.6% to trade at $11.21 on Thursday.</p>\n<p>These analysts made changes to their price targets on Phreesia following earnings announcement.</p>\n<ul>\n<li><a href=\"https://laohu8.com/S/EOD\">Wells Fargo</a> analyst Stan Berenshteyn maintained the stock with an Equal-Weight rating and raised the price target from $9 to $10.</li>\n<li>Needham analyst Ryan MacDonald reiterated the stock with a Buy and maintained a $14 price target.</li>\n<li>RBC Capital analyst Ryan Halsted reiterated the stock with an Outperform rating and maintained a $19 price target.</li>\n</ul>\n<p><strong>Considering buying PHR stock? Here’s what analysts think:</strong></p>\n<figure><img decoding=\"async\" height=\"314\" loading=\"lazy\" sizes=\"(max-width: 1024px) 100vw, 1024px\" src=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/09/03102307/image-90-1024x314.png\" srcset=\"https://editorial-assets.benzinga.com/wp-content/uploads/2026/09/03102307/image-90-1024x314.png 1024w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/09/03102307/image-90-300x92.png 300w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/09/03102307/image-90-768x235.png 768w, https://editorial-assets.benzinga.com/wp-content/uploads/2026/09/03102307/image-90.png 1162w\" width=\"1024\"/></figure>\n<p><em>Photo via Shutetrstock</em></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4167","symbol_name":"医疗保健技术","start_time":0,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/09/61604715/these-analysts-revise-their-forecasts-on-phreesia-after-q2-results","article_id":"2664487027","we_media_id":"1052270027","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2664487027","pubTimestamp":1788445460,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Benzinga Earnings","introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"summary":"Phreesia&#39;s Q2 EPS missed estimates, while sales beat. FY27 guidance held; shares fell 5.6%. Analysts kept bullish targets, Wells Fargo raised to $10.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4167":"医疗保健技术","PHR":"Phreesia, Inc."},"translate_title":"这些分析师在第二季度业绩后修改了对 Phreesia 的预测","themeId":"11c8fbbf839f433c9d274cef5f173382","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PHR":1},"content_text":"Phreesia Inc (NYSE:PHR) on Wednesday reported mixed second-quarter financial results.\nPhreesia reported quarterly earnings of 3 cents per share which missed the analyst consensus estimate of 10 cents per share. The company reported quarterly sales of $129.458 million which beat the analyst consensus estimate of $129.069 million.\nPhreesia affirmed its FY2027 sales guidance of $510.000 million to $520.000 million.\nPhreesia shares fell 5.6% to trade at $11.21 on Thursday.\nThese analysts made changes to their price targets on Phreesia following earnings announcement.\n\nWells Fargo analyst Stan Berenshteyn maintained the stock with an Equal-Weight rating and raised the price target from $9 to $10.\nNeedham analyst Ryan MacDonald reiterated the stock with a Buy and maintained a $14 price target.\nRBC Capital analyst Ryan Halsted reiterated the stock with an Outperform rating and maintained a $19 price target.\n\nConsidering buying PHR stock? Here’s what analysts think:\n\nPhoto via Shutetrstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"express","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}